Literature DB >> 8940276

Linkage of frontotemporal dementia to chromosome 17: clinical and neuropathological characterization of phenotype.

L H Yamaoka1, K A Welsh-Bohmer, C M Hulette, P C Gaskell, M Murray, J L Rimmler, B R Helms, M Guerra, A D Roses, D E Schmechel, M A Pericak-Vance.   

Abstract

Frontotemporal dementia is a behavioral disorder of insidious onset and variable progression. Clinically, its early features reflect frontal lobe dysfunction characterized by personality change, deterioration in memory and executive functions, and stereotypical and perseverative behaviors. Pathologically, there is degeneration of the neocortex and subcortical nuclei, without distinctive features such as plaques, neurofibrillary tangles, or Pick or Lewy bodies. Within-family variation in neuropathology and clinical phenotype is observed. In cases where family aggregation is observed, it is inherited as an autosomal dominant, age-dependent disorder. Family studies recently have identified two dementia loci: chromosome 17 for disinhibition-dementia-parkinsonism-amyotrophic complex and pallido-ponto-nigral degeneration and chromosome 3 for familial nonspecific dementia. We describe a family (DUK1684) with clinically and neuropathologically confirmed, autosomal dominant, non-Alzheimer disease dementia. Linkage analysis of this family showed evidence for linkage to chromosome 17q21, with a multipoint location score (log10) of 5.52. A comparison of the clinical and pathological features in DUK1684 with those of the other chromosome 17-linked families, together with the linkage data, suggests that these families are allelic. These studies emphasize that genetic linkage analysis remains a useful tool for differentiating disease loci in clinically complex traits.

Entities:  

Mesh:

Year:  1996        PMID: 8940276      PMCID: PMC1914881     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

1.  Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21.

Authors:  M Wijker; Z K Wszolek; E C Wolters; M A Rooimans; G Pals; R F Pfeiffer; T Lynch; R L Rodnitzky; K C Wilhelmsen; F Arwert
Journal:  Hum Mol Genet       Date:  1996-01       Impact factor: 6.150

2.  Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  K A Welsh; N Butters; J P Hughes; R C Mohs; A Heyman
Journal:  Arch Neurol       Date:  1992-05

3.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

Review 4.  Abnormal brain glucose metabolism in Alzheimer's disease, as measured by position emission tomography.

Authors:  S I Rapoport; B Horwitz; C L Grady; J V Haxby; C DeCarli; M B Schapiro
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

5.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

6.  Neuropsychiatric studies in a family with presenile dementia different from Alzheimer and Pick disease.

Authors:  S Gydesen; S Hagen; L Klinken; J Abelskov; S A Sørensen
Journal:  Acta Psychiatr Scand       Date:  1987-09       Impact factor: 6.392

7.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

8.  Familial non-specific dementia maps to chromosome 3.

Authors:  J Brown; A Ashworth; S Gydesen; A Sorensen; M Rossor; J Hardy; J Collinge
Journal:  Hum Mol Genet       Date:  1995-09       Impact factor: 6.150

9.  Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14.

Authors:  G D Schellenberg; T D Bird; E M Wijsman; H T Orr; L Anderson; E Nemens; J A White; L Bonnycastle; J L Weber; M E Alonso
Journal:  Science       Date:  1992-10-23       Impact factor: 47.728

10.  The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recoding and fuzzy inheritance.

Authors:  J R O'Connell; D E Weeks
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

View more
  9 in total

1.  Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17.

Authors:  J R Murrell; D Koller; T Foroud; M Goedert; M G Spillantini; H J Edenberg; M R Farlow; B Ghetti
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

2.  Assignment of the locus for PLO-SL, a frontal-lobe dementia with bone cysts, to 19q13.

Authors:  P Pekkarinen; I Hovatta; P Hakola; O Järvi; M Kestilä; U Lenkkeri; R Adolfsson; G Holmgren; P O Nylander; L Tranebjaerg; J D Terwilliger; J Lönnqvist; L Peltonen
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

3.  Severe amygdala dysfunction in a MAPT transgenic mouse model of frontotemporal dementia.

Authors:  Casey Cook; Judy H Dunmore; Melissa E Murray; Kristyn Scheffel; Nawsheen Shukoor; Jimei Tong; Monica Castanedes-Casey; Virginia Phillips; Linda Rousseau; Michael S Penuliar; Aishe Kurti; Dennis W Dickson; Leonard Petrucelli; John D Fryer
Journal:  Neurobiol Aging       Date:  2013-12-26       Impact factor: 4.673

Review 4.  Genetics of Frontotemporal Dementia.

Authors:  Diana A Olszewska; Roisin Lonergan; Emer M Fallon; Tim Lynch
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

5.  A Huntington disease-like neurodegenerative disorder maps to chromosome 20p.

Authors:  F Xiang; E W Almqvist; M Huq; A Lundin; M R Hayden; L Edström; M Anvret; Z Zhang
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

6.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands.

Authors:  P Rizzu; J C Van Swieten; M Joosse; M Hasegawa; M Stevens; A Tibben; M F Niermeijer; M Hillebrand; R Ravid; B A Oostra; M Goedert; C M van Duijn; P Heutink
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

7.  The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family.

Authors:  Salvatore Spina; Martin R Farlow; Frederick W Unverzagt; David A Kareken; Jill R Murrell; Graham Fraser; Francine Epperson; R Anthony Crowther; Maria G Spillantini; Michel Goedert; Bernardino Ghetti
Journal:  Brain       Date:  2007-12-07       Impact factor: 13.501

8.  Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements.

Authors:  I D'Souza; P Poorkaj; M Hong; D Nochlin; V M Lee; T D Bird; G D Schellenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

9.  Inheritance of frontotemporal dementia.

Authors:  T W Chow; B L Miller; V N Hayashi; D H Geschwind
Journal:  Arch Neurol       Date:  1999-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.